-
1
-
-
0038257951
-
-
Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. April 1999. 11th Annual Report
-
United States Renal Data System. 1999 Annual data report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. April 1999. 11th Annual Report.
-
(1999)
Annual Data Report
-
-
-
2
-
-
0036317169
-
The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants
-
Mauer M, Drummond K. The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. Diabetes 2002; 51:1572-1579. This describes the clinical and laboratorial characteristics of a large group of young type 1 diabetic patients participating in a multicenter study of the early history of diabetic nephropathy.
-
(2002)
Diabetes
, vol.51
, pp. 1572-1579
-
-
Mauer, M.1
Drummond, K.2
-
3
-
-
0036316997
-
The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes
-
Drummond K, Mauer M. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002; 51:1580-1587. The authors describe the renal structural findings and structural-functional relationships of a large group of young type 1 diabetic patients participating in a multicenter study of the early history of diabetic nephropathy.
-
(2002)
Diabetes
, vol.51
, pp. 1580-1587
-
-
Drummond, K.1
Mauer, M.2
-
4
-
-
0036068369
-
Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes
-
Caramori ML, Kim Y, Huang C, et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 2002; 51:506-513. This describes the renal structural findings and structural-functional relationships of long-standing type 1 diabetic patients with a wide range of clinical findings.
-
(2002)
Diabetes
, vol.51
, pp. 506-513
-
-
Caramori, M.L.1
Kim, Y.2
Huang, C.3
-
5
-
-
0036789206
-
Podocyte number in normotensive type 1 diabetic patients with albuminuria
-
White KE, Bilous RW, Marshall SM, et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes 2002; 51:3083-3089.
-
(2002)
Diabetes
, vol.51
, pp. 3083-3089
-
-
White, K.E.1
Bilous, R.W.2
Marshall, S.M.3
-
6
-
-
0031029379
-
Podocyte loss and progressive glomerular injury in type II diabetes
-
Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin invest 1997; 99:342-348.
-
(1997)
J Clin Invest
, vol.99
, pp. 342-348
-
-
Pagtalunan, M.E.1
Miller, P.L.2
Jumping-Eagle, S.3
-
7
-
-
0032710966
-
Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria
-
Meyer TW, Bennett PH, Nelson RG, Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 1999; 42:1341-1344.
-
(1999)
Diabetologia
, vol.42
, pp. 1341-1344
-
-
Meyer, T.W.1
Bennett, P.H.2
Nelson, R.G.3
-
8
-
-
0036098930
-
An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients
-
Katz A, Caramori ML, Sisson-Ross S, et al. An increase in the cell component of the cortical interstitium antedates interstitial fibrosis in type 1 diabetic patients. Kidney Int 2002; 61:2058-2066. The authors evaluated in detail the interstitial composition of long-standing type 1 diabetic patients.
-
(2002)
Kidney Int
, vol.61
, pp. 2058-2066
-
-
Katz, A.1
Caramori, M.L.2
Sisson-Ross, S.3
-
10
-
-
0036016901
-
Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients
-
Moriya T, Moriya R, Yajima Y, et al. Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients. Nephron 2002; 91:292-299.
-
(2002)
Nephron
, vol.91
, pp. 292-299
-
-
Moriya, T.1
Moriya, R.2
Yajima, Y.3
-
11
-
-
0033843758
-
Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease
-
White KE, Bilous RW. Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. J Am Soc Nephrol 2000; 11:1667-1673.
-
(2000)
J Am Soc Nephrol
, vol.11
, pp. 1667-1673
-
-
White, K.E.1
Bilous, R.W.2
-
12
-
-
0036839440
-
Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients
-
Baggio B, Budakovic A, Vestra MD, et al. Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients. J Am Soc Nephrol 2002; 13:2730-2736.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 2730-2736
-
-
Baggio, B.1
Budakovic, A.2
Vestra, M.D.3
-
13
-
-
0036176173
-
Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition
-
Chuahirun T, Wesson DE. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis 2002; 39:376-382.
-
(2002)
Am J Kidney Dis
, vol.39
, pp. 376-382
-
-
Chuahirun, T.1
Wesson, D.E.2
-
14
-
-
0036194517
-
Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies
-
Mazzucco G, Bertani T, Fortunato M, et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis 2002; 39:713-720.
-
(2002)
Am J Kidney Dis
, vol.39
, pp. 713-720
-
-
Mazzucco, G.1
Bertani, T.2
Fortunato, M.3
-
15
-
-
0026591207
-
An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus
-
Hayashi H, Karasawa R, Inn H, et al. An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int 1992; 41:749-757.
-
(1992)
Kidney Int
, vol.41
, pp. 749-757
-
-
Hayashi, H.1
Karasawa, R.2
Inn, H.3
-
16
-
-
0036190236
-
Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria
-
Bangstad HJ, Osterby R, Rudberg S, et al. Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia 2002; 45:253-261. The article reports on structural-functional relationships of microalbuminuric type 1 diabetic patients undergoing sequential kidney biopsies.
-
(2002)
Diabetologia
, vol.45
, pp. 253-261
-
-
Bangstad, H.J.1
Osterby, R.2
Rudberg, S.3
-
17
-
-
0035988186
-
Structural changes in renal arterioles in Type I diabetic patients
-
Osterby R, Hartmann A, Bangstad HJ. Structural changes in renal arterioles in Type I diabetic patients. Diabetologia 2002; 45:542-549. This reports on arteriolar structure in sequential kidney biopsies from microalbuminuric type 1 diabetic patients.
-
(2002)
Diabetologia
, vol.45
, pp. 542-549
-
-
Osterby, R.1
Hartmann, A.2
Bangstad, H.J.3
-
18
-
-
0037093012
-
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
-
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287:2563-2569. This paper summarizes the findings of the DCCT, and the subsequent observational follow-up of the DGGT cohort in the EDIC study, regarding the persistent effects of intensive treatment on reducing the microvascular complications of type 1 diabetes.
-
(2002)
JAMA
, vol.287
, pp. 2563-2569
-
-
-
19
-
-
0033946110
-
Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: Relation to glomerular hyperfiltration
-
Chiarelli F, Cipollone F, Romano F, et al. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes 2000; 49:1258-1263.
-
(2000)
Diabetes
, vol.49
, pp. 1258-1263
-
-
Chiarelli, F.1
Cipollone, F.2
Romano, F.3
-
20
-
-
0036363163
-
Chronic diabetic nephropathy: Role of inducible nitric oxide synthase
-
Trachtman H, Futterweit S, Pine E, et al. Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol 2002; 17:20-29.
-
(2002)
Pediatr Nephrol
, vol.17
, pp. 20-29
-
-
Trachtman, H.1
Futterweit, S.2
Pine, E.3
-
21
-
-
0036189833
-
Decreased matrix degradation in diabetic nephropathy: Effects of ACE inhibition on the expression and activities of matrix metalloproteinases
-
McLennan SV, Kelly DJ, Cox AJ, et al. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 2002; 45:268-275.
-
(2002)
Diabetologia
, vol.45
, pp. 268-275
-
-
McLennan, S.V.1
Kelly, D.J.2
Cox, A.J.3
-
22
-
-
0036020933
-
Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: Differing effects of anti-proteinuric therapies
-
Kelly DJ, Aaltonen P, Cox AJ, et al. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies. Nephrol Dial Transplant 2002; 17:1327-1332.
-
(2002)
Nephrol Dial Transplant
, vol.17
, pp. 1327-1332
-
-
Kelly, D.J.1
Aaltonen, P.2
Cox, A.J.3
-
23
-
-
0036433059
-
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: Effects of angiotensin converting enzyme inhibition
-
Langham RG, Kelly DJ, Cox AJ, et al. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 2002; 45:1572-1576.
-
(2002)
Diabetologia
, vol.45
, pp. 1572-1576
-
-
Langham, R.G.1
Kelly, D.J.2
Cox, A.J.3
-
24
-
-
0035987906
-
Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats
-
Kalender B, Ozturk M, Tuncdemir M, et al. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats. Acta Histochem 2002; 104:123-130.
-
(2002)
Acta Histochem
, vol.104
, pp. 123-130
-
-
Kalender, B.1
Ozturk, M.2
Tuncdemir, M.3
-
25
-
-
0036236554
-
Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes
-
Mizuno M, Sada T, Kato M, et al. Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes. Hypertens Res 2002; 25:271-278.
-
(2002)
Hypertens Res
, vol.25
, pp. 271-278
-
-
Mizuno, M.1
Sada, T.2
Kato, M.3
-
26
-
-
0036596686
-
Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: Effects of angiotensin receptor blockade and sodium restriction
-
Houlihan CA, Akdeniz A, Tsalamandris C, et al. Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction. Diabetes Care 2002; 25:1072-1077.
-
(2002)
Diabetes Care
, vol.25
, pp. 1072-1077
-
-
Houlihan, C.A.1
Akdeniz, A.2
Tsalamandris, C.3
-
27
-
-
0036723888
-
Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy
-
Satko SG, Langefeld CD, Daeihagh P, et al. Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis 2002: 40:489-494. Describes the prevalence of nephropathy in a large number of diabetic sibling pairs from African American families with type 2 diabetes and overt diabetic nephropathy.
-
(2002)
Am J Kidney Dis
, vol.40
, pp. 489-494
-
-
Satko, S.G.1
Langefeld, C.D.2
Daeihagh, P.3
-
28
-
-
17744421301
-
Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23
-
Vardarli I, Baier LJ, Hanson RL, et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 2002; 62:2176-2183.
-
(2002)
Kidney Int
, vol.62
, pp. 2176-2183
-
-
Vardarli, I.1
Baier, L.J.2
Hanson, R.L.3
-
29
-
-
0036181795
-
Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients
-
Fradin S, Goulet-Salmon B, Chantepie M, et al. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Diabetes Metab 2002; 28:27-32.
-
(2002)
Diabetes Metab
, vol.28
, pp. 27-32
-
-
Fradin, S.1
Goulet-Salmon, B.2
Chantepie, M.3
-
30
-
-
0035992566
-
ACE and PC-1 gene polymorphisms in normoalbuminuric Type 1 diabetic patients: A 10-year prospective study
-
de Azevedo MJ, Dalmaz CA, Caramori ML, et al. ACE and PC-1 gene polymorphisms in normoalbuminuric Type 1 diabetic patients: a 10-year prospective study. J Diabetes Complications 2002; 16:255-262.
-
(2002)
J Diabetes Complications
, vol.16
, pp. 255-262
-
-
De Azevedo, M.J.1
Dalmaz, C.A.2
Caramori, M.L.3
-
31
-
-
0035993273
-
The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: Evidence for a polygenic control of kidney disease progression
-
De Cosmo S, Miscio G, Zucaro L, et al. The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression. Nephrol Dial Transplant 2002; 17:1402-1407. Investigates ACE and ENPP1 (PC-1) polymorphisms as predictors of development or progression of diabetic nephropathy in type 1 diabetic patients.
-
(2002)
Nephrol Dial Transplant
, vol.17
, pp. 1402-1407
-
-
De Cosmo, S.1
Miscio, G.2
Zucaro, L.3
-
32
-
-
0036332371
-
Angiotensin converting enzyme gene polymorphism and glomerular filtration rate changes in type 2 diabetic patients
-
Araz M, Okan V, Celen Z, et al. Angiotensin converting enzyme gene polymorphism and glomerular filtration rate changes in type 2 diabetic patients. Int J Clin Pract 2002; 56:416-418.
-
(2002)
Int J Clin Pract
, vol.56
, pp. 416-418
-
-
Araz, M.1
Okan, V.2
Celen, Z.3
-
33
-
-
0036097534
-
The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes
-
Solini A, Dalla Vestra M, Saller A, et al. The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. Diabetes 2002; 51:251-255. Explores the relationship between diabetic glomerulopathy and ACE genotype in microalbuminuric and proteinuric type 2 diabetic patients.
-
(2002)
Diabetes
, vol.51
, pp. 251-255
-
-
Solini, A.1
Dalla Vestra, M.2
Saller, A.3
-
34
-
-
0036011343
-
Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients
-
Maltais I, Bachvarova M, Maheux P, et al. Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients. Can J Physiol Pharmacol 2002; 80:323-327.
-
(2002)
Can J Physiol Pharmacol
, vol.80
, pp. 323-327
-
-
Maltais, I.1
Bachvarova, M.2
Maheux, P.3
-
35
-
-
0036231891
-
Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes
-
Canani LH, Ng DP, Smiles A, et al. Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes 2002; 51:1188-1193. This describes the results of a case-control study and a family-based study evaluating the association between ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene polymorphism and advanced diabetic nephropathy in patients with type 1 diabetes.
-
(2002)
Diabetes
, vol.51
, pp. 1188-1193
-
-
Canani, L.H.1
Ng, D.P.2
Smiles, A.3
-
36
-
-
0036426805
-
Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study
-
Orchard TJ, Chang YF, Ferrell RE, et al. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002; 62:963-970. The authors evaluated the role of insulin resistance and other variables as predictors of overt diabetic nephropathy in a large cohort of type 1 diabetic patients.
-
(2002)
Kidney Int
, vol.62
, pp. 963-970
-
-
Orchard, T.J.1
Chang, Y.F.2
Ferrell, R.E.3
-
37
-
-
0033651349
-
APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: Results of case-control and family-based studies
-
Araki S, Moczulski DK, Hanna L, et al. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. Diabetes 2000; 49:2190-2195.
-
(2000)
Diabetes
, vol.49
, pp. 2190-2195
-
-
Araki, S.1
Moczulski, D.K.2
Hanna, L.3
-
38
-
-
0036328342
-
Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients
-
Eto M, Saito M, Okada M, et al. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis 2002; 40:243-251.
-
(2002)
Am J Kidney Dis
, vol.40
, pp. 243-251
-
-
Eto, M.1
Saito, M.2
Okada, M.3
-
39
-
-
0036659004
-
Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan
-
Hsieh MC, Lin SR, Yang YC, et al. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan. J Nephrol 2002; 15:368-373.
-
(2002)
J Nephrol
, vol.15
, pp. 368-373
-
-
Hsieh, M.C.1
Lin, S.R.2
Yang, Y.C.3
-
40
-
-
0036320727
-
Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study
-
Herrmann SM, Ringel J, Wang JG, et al. Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. Diabetes 2002; 51:2653-2657. The results of this study suggested an association between the PPAR-γ2 Pro12Ala polymorphism and decreased risk of diabetic nephropathy in patients with type 2 diabetes.
-
(2002)
Diabetes
, vol.51
, pp. 2653-2657
-
-
Herrmann, S.M.1
Ringel, J.2
Wang, J.G.3
-
41
-
-
0036097735
-
Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes
-
Nakajima K, Tanaka Y, Nomiyama T, et al. Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes. Diabetes 2002; 51:238-242.
-
(2002)
Diabetes
, vol.51
, pp. 238-242
-
-
Nakajima, K.1
Tanaka, Y.2
Nomiyama, T.3
-
42
-
-
0036741894
-
Leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) polymorphism is associated with diabetic nephropathy in type 2 diabetes mellitus
-
Kamiuchi K, Hasegawa G, Obayashi H, et al. Leukocyte-endothelial cell adhesion molecule 1 (LECAM-1) polymorphism is associated with diabetic nephropathy in type 2 diabetes mellitus. J Diabetes Complications 2002; 16:333-337.
-
(2002)
J Diabetes Complications
, vol.16
, pp. 333-337
-
-
Kamiuchi, K.1
Hasegawa, G.2
Obayashi, H.3
-
43
-
-
0036300030
-
Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes
-
Ng DP, Canani L, Araki S, et al. Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes. Diabetes 2002; 51:2264-2269. These authors report an association between GLUT-1 polymorphisms and increased risk of diabetic nephropathy in a subset of type 1 diabetic patients.
-
(2002)
Diabetes
, vol.51
, pp. 2264-2269
-
-
Ng, D.P.1
Canani, L.2
Araki, S.3
-
44
-
-
0032143644
-
GLUT1 gene polymorphism in noninsulin-dependent diabetes mellitus: Genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population
-
Gutierrez C, Vendrell J, Pastor R, et al. GLUT1 gene polymorphism in noninsulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population. Diabetes Res Clin Pract 1998; 41:113-120.
-
(1998)
Diabetes Res Clin Pract
, vol.41
, pp. 113-120
-
-
Gutierrez, C.1
Vendrell, J.2
Pastor, R.3
-
45
-
-
0036182269
-
Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes
-
Morris BJ, Markus A, Glenn CL, et al. Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes. J Mol Med 2002; 80:96-104.
-
(2002)
J Mol Med
, vol.80
, pp. 96-104
-
-
Morris, B.J.1
Markus, A.2
Glenn, C.L.3
-
46
-
-
0036230806
-
Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes
-
Kao Y, Donaghue KC, Chan A, et al. Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes. Diabet Med 2002; 19:212-215.
-
(2002)
Diabet Med
, vol.19
, pp. 212-215
-
-
Kao, Y.1
Donaghue, K.C.2
Chan, A.3
-
47
-
-
0036972917
-
Endothelial nitric oxide synthase gene and the development of diabetic nephropathy
-
Shimizu T, Onuma T, Kawamori R, et al. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract 2002; 58:179-185.
-
(2002)
Diabetes Res Clin Pract
, vol.58
, pp. 179-185
-
-
Shimizu, T.1
Onuma, T.2
Kawamori, R.3
-
48
-
-
0036125236
-
Diabetic nephropathy is associated with the 5′-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with Type 2 diabetes
-
Liu YF, Wat NM, Chung SS, et al. Diabetic nephropathy is associated with the 5′-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with Type 2 diabetes. Diabet Med 2002; 19:113-118.
-
(2002)
Diabet Med
, vol.19
, pp. 113-118
-
-
Liu, Y.F.1
Wat, N.M.2
Chung, S.S.3
-
49
-
-
0036143666
-
(AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus
-
Park HK, Ahn CW, Lee GT, et al. (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus. Diabetes Res Clin Pract 2002; 55:151-157.
-
(2002)
Diabetes Res Clin Pract
, vol.55
, pp. 151-157
-
-
Park, H.K.1
Ahn, C.W.2
Lee, G.T.3
-
50
-
-
18544388557
-
The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes
-
De Cosmo S, Tassi V, Thomas S, et al. The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes. Nephron 2002; 92:72-76.
-
(2002)
Nephron
, vol.92
, pp. 72-76
-
-
De Cosmo, S.1
Tassi, V.2
Thomas, S.3
-
51
-
-
0036380319
-
Mesangial cell-predominant gene, megsin
-
Inagi R, Miyata T, Imasawa T, et al. Mesangial cell-predominant gene, megsin. Nephrol Dial Transplant 2002; 17 (Suppl 9):32-33.
-
(2002)
Nephrol Dial Transplant
, vol.17
, Issue.SUPPL. 9
, pp. 32-33
-
-
Inagi, R.1
Miyata, T.2
Imasawa, T.3
-
52
-
-
0036717048
-
Role of nephrin in renal disease including diabetic nephropathy
-
Cooper ME, Mundel P, Boner G. Role of nephrin in renal disease including diabetic nephropathy. Semin Nephrol 2002; 22:393-398.
-
(2002)
Semin Nephrol
, vol.22
, pp. 393-398
-
-
Cooper, M.E.1
Mundel, P.2
Boner, G.3
-
53
-
-
0035991118
-
Gremlins: Is this what renal fibrogenesis has come to?
-
Murphy M, McMahon R, Lappin DW, et al. Gremlins: is this what renal fibrogenesis has come to? Exp Nephrol 2002; 10:241-244.
-
(2002)
Exp Nephrol
, vol.10
, pp. 241-244
-
-
Murphy, M.1
McMahon, R.2
Lappin, D.W.3
-
54
-
-
0036385254
-
Gremlin: An example of the reemergence of developmental programmes in diabetic nephropathy
-
Lappin DW, McMahon R, Murphy M, et al. Gremlin: an example of the reemergence of developmental programmes in diabetic nephropathy. Nephrol Dial Transplant 2002; 17 (Suppl 9):65-67.
-
(2002)
Nephrol Dial Transplant
, vol.17
, Issue.SUPPL. 9
, pp. 65-67
-
-
Lappin, D.W.1
McMahon, R.2
Murphy, M.3
-
55
-
-
0036177882
-
Gene expression and identification of gene therapy targets in diabetic nephropathy
-
Wada J, Makino H, Kanwar YS. Gene expression and identification of gene therapy targets in diabetic nephropathy. Kidney Int Suppl 2002; 61 (Suppl 1):73-78.
-
(2002)
Kidney Int Suppl
, vol.61
, Issue.SUPPL. 1
, pp. 73-78
-
-
Wada, J.1
Makino, H.2
Kanwar, Y.S.3
-
56
-
-
0037920442
-
Pathophysiology of renal complications
-
Porte D, editor. New York: McGraw-Hill
-
Caramori MLA, Mauer M. Pathophysiology of renal complications. In: Porte D, editor. Ellemberg & Rifkin's diabetes mellitus. 6th ed. New York: McGraw-Hill; 2002. pp. 697-721. This is a thorough review on the pathophysiology of diabetic nephropathy.
-
(2002)
Ellemberg & Rifkin's Diabetes Mellitus. 6th Ed.
, pp. 697-721
-
-
Caramori, M.L.A.1
Mauer, M.2
-
57
-
-
0036829908
-
High glucose stimulates synthesis of fibronectin via a novel protein kinase C, Rap1b, and B-Raf signaling pathway
-
Lin S, Sahai A, Chugh SS, et al. High glucose stimulates synthesis of fibronectin via a novel protein kinase C, Rap1b, and B-Raf signaling pathway. J Biol Chem 2002; 277:41725-41735. This study suggested a novel pathway associated with high glucose-induced mesangial matrix synthesis.
-
(2002)
J Biol Chem
, vol.277
, pp. 41725-41735
-
-
Lin, S.1
Sahai, A.2
Chugh, S.S.3
-
58
-
-
0033814068
-
Role of growth factors in the development of diabetic complications
-
Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications. Horm Res 2000; 53:53-67.
-
(2000)
Horm Res
, vol.53
, pp. 53-67
-
-
Chiarelli, F.1
Santilli, F.2
Mohn, A.3
-
59
-
-
0036735194
-
Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor
-
Fraser D, Wakefield L, Phillips A. Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor. Am J Pathol 2002; 161:1039-1049.
-
(2002)
Am J Pathol
, vol.161
, pp. 1039-1049
-
-
Fraser, D.1
Wakefield, L.2
Phillips, A.3
-
60
-
-
0036786249
-
Connective tissue growth factor and regulation of the mesangial cell cycle: Role in cellular hypertrophy
-
Abdel-Wahab N, Weston BS, Roberts T, et al. Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. J Am Soc Nephrol 2002; 13:2437-2445. These investigators evaluated the effects of CTGF on mesangial cell cycle.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 2437-2445
-
-
Abdel-Wahab, N.1
Weston, B.S.2
Roberts, T.3
-
61
-
-
0033760187
-
AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells
-
Weigert C, Sauer U, Brodbeck K, et al. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells. J Am Soc Nephrol 2000; 11:2007-2016.
-
(2000)
J Am Soc Nephrol
, vol.11
, pp. 2007-2016
-
-
Weigert, C.1
Sauer, U.2
Brodbeck, K.3
-
62
-
-
0036895640
-
Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes
-
Huang C, Kim Y, Caramori ML, et al. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Diabetes 2002; 51:3577-3581. This describes differences in messenger RNA expression levels of TGF-β system components in cultured skin fibroblasts from type 1 diabetic patients with fast versus slow development of diabetic nephropathy lesions.
-
(2002)
Diabetes
, vol.51
, pp. 3577-3581
-
-
Huang, C.1
Kim, Y.2
Caramori, M.L.3
-
63
-
-
0036086797
-
Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation
-
Zheng F, Fornoni A, Elliot SJ, et al. Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation. Am J Physiol Renal Physiol 2002; 282:F639-F648. The study examined the regulation of type I collagen expression by PPARγ and TGF-β1 in mouse mesangial cells exposed to normal and high glucose.
-
(2002)
Am J Physiol Renal Physiol
, vol.282
-
-
Zheng, F.1
Fornoni, A.2
Elliot, S.J.3
-
64
-
-
0036098955
-
Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy
-
Paueksakon P, Revelo MP, Ma LJ, et al. Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy. Kidney Int 2002; 61:2142-2148. This evaluated the role of plasminogen activator inhibitor-1 and PPARγ on diabetic nephropathy microvascular injury.
-
(2002)
Kidney Int
, vol.61
, pp. 2142-2148
-
-
Paueksakon, P.1
Revelo, M.P.2
Ma, L.J.3
-
65
-
-
33751299571
-
Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells
-
Natarajan R, Bai W, Lanting L, et al. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 1997; 273:H2224-H2231.
-
(1997)
Am J Physiol Heart Circ Physiol
, vol.273
-
-
Natarajan, R.1
Bai, W.2
Lanting, L.3
-
66
-
-
0033851522
-
Role of vascular endothelial growth factor in diabetic nephropathy
-
Cha DR, Kim NH, Yoon JW, et al. Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int 2000; 58 (Suppl 77):S104-S112.
-
(2000)
Kidney Int
, vol.58
, Issue.SUPPL. 77
-
-
Cha, D.R.1
Kim, N.H.2
Yoon, J.W.3
-
67
-
-
0034046347
-
Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells
-
Kim NH, Jung HH, Cha DR, et al. Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells. J Endocrinol 2000; 165:617-624.
-
(2000)
J Endocrinol
, vol.165
, pp. 617-624
-
-
Kim, N.H.1
Jung, H.H.2
Cha, D.R.3
-
68
-
-
0036289551
-
High glucose induced VEGF expression via PKC and ERK in glomerular podocytes
-
Hoshi S, Nomoto K, Kuromitsu J, et al. High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun 2002; 290:177-184. These authors investigated the role of PKC and extracellular signal-regulated kinase on high glucose-induced podocyte vascular endothelial growth factor expression.
-
(2002)
Biochem Biophys Res Commun
, vol.290
, pp. 177-184
-
-
Hoshi, S.1
Nomoto, K.2
Kuromitsu, J.3
-
69
-
-
0030863502
-
Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro
-
Williams B, Gallacher B, Patel H, et al. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 1997; 46:1497-1503.
-
(1997)
Diabetes
, vol.46
, pp. 1497-1503
-
-
Williams, B.1
Gallacher, B.2
Patel, H.3
-
70
-
-
0036789207
-
Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody
-
Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, et al. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 2002; 51:3090-3094. This examines the effects of a neutralizing vascular endothelial growth factor antibody on renal structure and function of db/db diabetic mice.
-
(2002)
Diabetes
, vol.51
, pp. 3090-3094
-
-
Flyvbjerg, A.1
Dagnaes-Hansen, F.2
De Vriese, A.S.3
-
71
-
-
0036183786
-
High glucose down-regulates angiotensin II binding via the PKC-MAPK-cPLA2 signal cascade in renal proximal tubule cells
-
Park SH, Woo CH, Kim JH, et al. High glucose down-regulates angiotensin II binding via the PKC-MAPK-cPLA2 signal cascade in renal proximal tubule cells. Kidney Int 2002; 61:913-925. This study evaluated the effects of high glucose on arachidonic acid and angiotensin II binding in renal proximal tubular cells.
-
(2002)
Kidney Int
, vol.61
, pp. 913-925
-
-
Park, S.H.1
Woo, C.H.2
Kim, J.H.3
-
72
-
-
0036083521
-
The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells
-
Park SH, Han HJ. The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells. Am J Physiol Renal Physiol 2002; 282:F228-F237. The authors investigated the signal pathways involved in high-glucose-induced downregulation of angiotensin II binding in renal proximal tubular cells.
-
(2002)
Am J Physiol Renal Physiol
, vol.282
-
-
Park, S.H.1
Han, H.J.2
-
73
-
-
0036236158
-
Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose
-
Amiri F, Shaw S, Wang X, et al. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int 2002; 61:1605-1616.
-
(2002)
Kidney Int
, vol.61
, pp. 1605-1616
-
-
Amiri, F.1
Shaw, S.2
Wang, X.3
-
74
-
-
0036597884
-
Angiotensin II induces human TGF-beta 1 promoter activation: Similarity to hyperglycaemia
-
Weigert C, Brodbeck K, Klopfer K, et al. Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia. Diabetologia 2002; 45:890-898. In this paper the authors describe the molecular mechanism of angiotensin II-induced TGF-β1 gene activation in mesangial cells.
-
(2002)
Diabetologia
, vol.45
, pp. 890-898
-
-
Weigert, C.1
Brodbeck, K.2
Klopfer, K.3
-
75
-
-
0036149122
-
Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats
-
Kelly DJ, Cox AJ, Tolcos M, et al. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int 2002; 61:31-39.
-
(2002)
Kidney Int
, vol.61
, pp. 31-39
-
-
Kelly, D.J.1
Cox, A.J.2
Tolcos, M.3
-
76
-
-
18644365067
-
Changes of endothelin in streptozotocin-induced diabetic rats: Effects of an angiotensin converting enzyme inhibitor, enalapril maleate
-
Itoh Y, Imamura S, Yamamoto K, et al. Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate. J Endocrinol 2002; 175:233-239.
-
(2002)
J Endocrinol
, vol.175
, pp. 233-239
-
-
Itoh, Y.1
Imamura, S.2
Yamamoto, K.3
-
77
-
-
0036073109
-
High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor
-
Tsiani E, Lekas P, Fantus IG, et al. High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor. Am J Physiol Endocrinol Metab 2002; 282:E161-E169.
-
(2002)
Am J Physiol Endocrinol Metab
, vol.282
-
-
Tsiani, E.1
Lekas, P.2
Fantus, I.G.3
-
78
-
-
0036839201
-
Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells
-
Reddy MA, Adler SG, Kim YS, et al. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells. Am J Physiol Renal Physiol 2002; 283:F985-F994. This suggests a novel interaction between lipoxygenase and p38 mitogen-activated protein kinase, and its association with diabetic nephropathy.
-
(2002)
Am J Physiol Renal Physiol
, vol.283
-
-
Reddy, M.A.1
Adler, S.G.2
Kim, Y.S.3
-
79
-
-
0037162699
-
Renal protective effect of YM598, a selective endothelin ET(A) receptor antagonist, against diabetic nephropathy in OLETF rats
-
Sugimoto K, Tsuruoka S, Fujimura A. Renal protective effect of YM598, a selective endothelin ET(A) receptor antagonist, against diabetic nephropathy in OLETF rats. Eur J Pharmacol 2002; 450:183-189.
-
(2002)
Eur J Pharmacol
, vol.450
, pp. 183-189
-
-
Sugimoto, K.1
Tsuruoka, S.2
Fujimura, A.3
-
80
-
-
0031724557
-
Urinary endothelin in adolescents and young adults with insulin-dependent diabetes mellitus: Relation to urinary albumin, blood pressure, and other factors
-
Peppa-Patrikiou M, Dracopoulou M, Dacou-Voutetakis C. Urinary endothelin in adolescents and young adults with insulin-dependent diabetes mellitus: relation to urinary albumin, blood pressure, and other factors. Metabolism 1998; 47:1408-1412.
-
(1998)
Metabolism
, vol.47
, pp. 1408-1412
-
-
Peppa-Patrikiou, M.1
Dracopoulou, M.2
Dacou-Voutetakis, C.3
-
81
-
-
0029834396
-
The correlation of plasma and urine endothelin-1 with the severity of nephropathy in Chinese patients with type 2 diabetes
-
Shin SJ, Lee YJ, Tsai JH. The correlation of plasma and urine endothelin-1 with the severity of nephropathy in Chinese patients with type 2 diabetes. Scand J Clin Lab Invest 1996; 56:571-576.
-
(1996)
Scand J Clin Lab Invest
, vol.56
, pp. 571-576
-
-
Shin, S.J.1
Lee, Y.J.2
Tsai, J.H.3
-
82
-
-
0036024034
-
Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients
-
Bruno CM, Meli S, Marcinno M, et al. Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients. J Biol Regul Homeost Agents 2002; 16:114-117.
-
(2002)
J Biol Regul Homeost Agents
, vol.16
, pp. 114-117
-
-
Bruno, C.M.1
Meli, S.2
Marcinno, M.3
-
83
-
-
0036998009
-
Serum angiogenin concentrations in young patients with diabetes mellitus
-
Chiarelli F, Pomilio M, Mohn A, et al. Serum angiogenin concentrations in young patients with diabetes mellitus. Eur J Clin Invest 2002; 32:110-114.
-
(2002)
Eur J Clin Invest
, vol.32
, pp. 110-114
-
-
Chiarelli, F.1
Pomilio, M.2
Mohn, A.3
-
84
-
-
0036084953
-
Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal
-
Rosca MG, Monnier VM, Szweda LI, et al. Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal. Am J Physiol Renal Physiol 2002; 283:F52-F59. The authors evaluated the toxic effects of methylglyoxal in renal mitochondria.
-
(2002)
Am J Physiol Renal Physiol
, vol.283
-
-
Rosca, M.G.1
Monnier, V.M.2
Szweda, L.I.3
-
85
-
-
0036317040
-
Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats
-
Kakimoto M, Inoguchi T, Sonta T, et al. Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes 2002; 51:1588-1595. This paper resports a dissection of the molecular mechanisms of oxidative mitochondrial DNA damage in diabetic rat kidneys.
-
(2002)
Diabetes
, vol.51
, pp. 1588-1595
-
-
Kakimoto, M.1
Inoguchi, T.2
Sonta, T.3
-
86
-
-
0036151673
-
Glucose-induced oxidative stress in mesangial cells
-
Catherwood MA, Powell LA, Anderson P, et al. Glucose-induced oxidative stress in mesangial cells. Kidney Int 2002; 61:599-608. This investigates the effects of high glucose and antioxidants on the levels of antioxidant enzymes in porcine mesangial cells, suggesting an etiological link between oxidative stress and increased extracellular matrix protein synthesis.
-
(2002)
Kidney Int
, vol.61
, pp. 599-608
-
-
Catherwood, M.A.1
Powell, L.A.2
Anderson, P.3
-
87
-
-
18644385337
-
Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells
-
Verzola D, Bertolotto MB, Villaggio B, et al. Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells. J Investig Med 2002; 50:443-451.
-
(2002)
J Investig Med
, vol.50
, pp. 443-451
-
-
Verzola, D.1
Bertolotto, M.B.2
Villaggio, B.3
-
88
-
-
0036252148
-
Dietary glutathione protects rats from diabetic nephropathy and neuropathy
-
Ueno Y, Kizaki M, Nakagiri R, et al. Dietary glutathione protects rats from diabetic nephropathy and neuropathy. J Nutr 2002; 132:897-900.
-
(2002)
J Nutr
, vol.132
, pp. 897-900
-
-
Ueno, Y.1
Kizaki, M.2
Nakagiri, R.3
-
89
-
-
0036016906
-
Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy
-
Kanauchi M, Nishioka H, Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 2002; 91:327-329. This investigation studied the relationship between oxidative DNA damage and tubulointerstitial injury in type 2 diabetic patients with diabetic nephropathy, suggesting that oxidative stress may contribute to progressive tubulointerstitial injury in diabetic nephropathy.
-
(2002)
Nephron
, vol.91
, pp. 327-329
-
-
Kanauchi, M.1
Nishioka, H.2
Hashimoto, T.3
-
90
-
-
0036596185
-
Urinary excretion of 8-oxo-7,8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy
-
Hinokio Y, Suzuki S, Hirai M, et al. Urinary excretion of 8-oxo-7,8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia 2002; 45:877-882. Describes an association between urinary excretion of a product of oxidative DNA damage and development of diabetic nephropathy in Japanese type 2 diabetic patients.
-
(2002)
Diabetologia
, vol.45
, pp. 877-882
-
-
Hinokio, Y.1
Suzuki, S.2
Hirai, M.3
-
91
-
-
0037036345
-
Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells
-
Yamagishi S, Inagaki Y, Okamoto T, et al. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem 2002; 277:20309-20315. These authors evaluated the effects of AGEs and N-acetylcysteine, an antioxidant, on human cultured mesangial cell growth and on vascular endothelial growth factor and MCP-1 mesangial cell protein expression.
-
(2002)
J Biol Chem
, vol.277
, pp. 20309-20315
-
-
Yamagishi, S.1
Inagaki, Y.2
Okamoto, T.3
-
92
-
-
0036323281
-
Effects of mesangium glycation on matrix metalloproteinase activities: Possible role in diabetic nephropathy
-
McLennan SV, Martell SK, Yue DK. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy. Diabetes 2002; 51:2612-2618. This confirms the inhibitory effects of mesangial matrix glycation on extracellular matrix turnover.
-
(2002)
Diabetes
, vol.51
, pp. 2612-2618
-
-
McLennan, S.V.1
Martell, S.K.2
Yue, D.K.3
-
93
-
-
0036830463
-
Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy
-
Forbes JM, Cooper ME, Thallas V, et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 2002; 51:3274-3282. The authors identify a relationship between the renin-angiotensin system and the accumulation of AGEs in experimental diabetic nephropathy, suggesting that these systems may be linked through oxidative stress.
-
(2002)
Diabetes
, vol.51
, pp. 3274-3282
-
-
Forbes, J.M.1
Cooper, M.E.2
Thallas, V.3
-
94
-
-
0036183727
-
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
-
Degenhardt TP, Alderson NL, Arrington DD, et al. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int 2002; 61:939-950.
-
(2002)
Kidney Int
, vol.61
, pp. 939-950
-
-
Degenhardt, T.P.1
Alderson, N.L.2
Arrington, D.D.3
-
95
-
-
0036892894
-
Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine
-
Twigg SM, Cao Z, SV MC, et al. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 2002; 143:4907-4915.
-
(2002)
Endocrinology
, vol.143
, pp. 4907-4915
-
-
Twigg, S.M.1
Cao, Z.2
Sv, M.C.3
-
96
-
-
0036253802
-
Effects of aminoguanidine on lipid and protein oxidation in diabetic rat kidneys
-
Gogasyavuz D, Kucukkaya B, Ersoz HO, et al. Effects of aminoguanidine on lipid and protein oxidation in diabetic rat kidneys. Int J Exp Diabetes Res 2002; 3:145-151.
-
(2002)
Int J Exp Diabetes Res
, vol.3
, pp. 145-151
-
-
Gogasyavuz, D.1
Kucukkaya, B.2
Ersoz, H.O.3
-
97
-
-
0036829609
-
ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat
-
Wilkinson-Berka JL, Kelly DJ, Koerner SM, et al. ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat. Diabetes 2002; 51:3283-3289.
-
(2002)
Diabetes
, vol.51
, pp. 3283-3289
-
-
Wilkinson-Berka, J.L.1
Kelly, D.J.2
Koerner, S.M.3
-
98
-
-
0036208878
-
Effects of aminoguanidine and tolrestat on the development of ocular and renal structural changes in experimental diabetic rats
-
Azal O, Yonem A, Guler S, et al. Effects of aminoguanidine and tolrestat on the development of ocular and renal structural changes in experimental diabetic rats. Diabetes Obes Metab 2002; 4:75-79.
-
(2002)
Diabetes Obes Metab
, vol.4
, pp. 75-79
-
-
Azal, O.1
Yonem, A.2
Guler, S.3
-
99
-
-
0035992568
-
The effects of aminoguanidine on renal changes in a baboon model of Type 1 diabetes
-
Birrell AM, Heffernan SJ, Kirwan P, et al. The effects of aminoguanidine on renal changes in a baboon model of Type 1 diabetes. J Diabetes Complications 2002; 16:301-309. This was the first study to investigate the efficacy of aminoguanidine on primary prevention of renal structural lesions in a primate model of type 1 diabetes.
-
(2002)
J Diabetes Complications
, vol.16
, pp. 301-309
-
-
Birrell, A.M.1
Heffernan, S.J.2
Kirwan, P.3
-
100
-
-
0036068029
-
Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice
-
Cohen MP, Hud E, Shea E, et al. Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice. Metabolism 2002; 51:901-905. This tested if urinary type IV collagen could be a marker of the efficacy of diabetic nephropathy treatment.
-
(2002)
Metabolism
, vol.51
, pp. 901-905
-
-
Cohen, M.P.1
Hud, E.2
Shea, E.3
-
101
-
-
0035985243
-
Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products
-
Zheng F, He C, Cai W, et al. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes Metab Res Rev 2002; 18:224-237. These authors demonstrate the contribution of diet-derived AGEs on the development of diabetic glomerular lesions in rodents.
-
(2002)
Diabetes Metab Res Rev
, vol.18
, pp. 224-237
-
-
Zheng, F.1
He, C.2
Cai, W.3
-
102
-
-
0037003333
-
Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients
-
Schalkwijk CG, Chaturvedi N, Twaafhoven H, et al. Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients. Eur J Clin Invest 2002; 32:500-506. This assesses the association of Amadori-albumin with early nephropathy and retinopathy in type 1 diabetic patients from the European Community Concerted Action Programme in Diabetes (EURODIAB) Controlled Trial of Lisinopril in Insulin Dependent Diabetes (EUCLID) study.
-
(2002)
Eur J Clin Invest
, vol.32
, pp. 500-506
-
-
Schalkwijk, C.G.1
Chaturvedi, N.2
Twaafhoven, H.3
-
103
-
-
0037155923
-
Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells
-
Wang S, Shiva S, Poczatek MH, et al. Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells. J Biol Chem 2002; 277:9880-9888. The authors evaluated the role of nitric oxide signaling in the regulation of thrombospondin 1 expression and thrombospondin 1-dependent TGF-β activity in rat mesangial cells exposed to high glucose.
-
(2002)
J Biol Chem
, vol.277
, pp. 9880-9888
-
-
Wang, S.1
Shiva, S.2
Poczatek, M.H.3
-
104
-
-
0035995344
-
Transforming growth factor-beta-1 latency-associated peptide and soluble betaglycan prevent a glucose-induced increase in fibronectin production in cultured human mesangial cells
-
Nomura K, Tada H, Kuboki K, et al. Transforming growth factor-beta-1 latency-associated peptide and soluble betaglycan prevent a glucose-induced increase in fibronectin production in cultured human mesangial cells. Nephron 2002; 91:606-611. This study investigated the effects of TGF-β latency-associated peptide and betaglycan on TGF-β1 activity, and on the glucose-induced overproduction of fibronectin in cultured human mesangial cells.
-
(2002)
Nephron
, vol.91
, pp. 606-611
-
-
Nomura, K.1
Tada, H.2
Kuboki, K.3
-
105
-
-
0037086552
-
Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Oa2+-dependent phosphorylation of Smad2 at serine-240
-
Abdel-Wahab N, Wicks SJ, Mason RM, et al. Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Oa2+-dependent phosphorylation of Smad2 at serine-240. Biochem J 2002; 362:643-649.
-
(2002)
Biochem J
, vol.362
, pp. 643-649
-
-
Abdel-Wahab, N.1
Wicks, S.J.2
Mason, R.M.3
-
106
-
-
12244298259
-
Differential expression of MCP-1 and its receptor CCR2 in glucose primed human mesangial cells
-
Janssen U, Sowa E, Marchand P, et al. Differential expression of MCP-1 and its receptor CCR2 in glucose primed human mesangial cells. Nephron 2002; 92:797-806.
-
(2002)
Nephron
, vol.92
, pp. 797-806
-
-
Janssen, U.1
Sowa, E.2
Marchand, P.3
-
107
-
-
0036781581
-
Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes
-
Chiarelli F, Cipollone F, Mohn A, et al. Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. Diabetes Care 2002; 25:1829-1834.
-
(2002)
Diabetes Care
, vol.25
, pp. 1829-1834
-
-
Chiarelli, F.1
Cipollone, F.2
Mohn, A.3
-
108
-
-
0035988193
-
Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus
-
Omoto S, Nomura S, Shouzu A, et al. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus. Diabetologia 2002; 45:550-555.
-
(2002)
Diabetologia
, vol.45
, pp. 550-555
-
-
Omoto, S.1
Nomura, S.2
Shouzu, A.3
-
109
-
-
18244407807
-
Urinary levels of monocyte chemoattractant protein-1 (MOP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy
-
Tashiro K, Koyanagi I, Saitoh A, et al. Urinary levels of monocyte chemoattractant protein-1 (MOP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 2002; 16:1-4. This examines the correlation among urinary levels of MCP-1 and interleukin-8, hyperglycemia, and renal injury, suggesting that measurement of urinary MOP-1 and interleukin-8 may be useful for evaluating the degree of renal injury in patients with type 2 diabetes.
-
(2002)
J Clin Lab Anal
, vol.16
, pp. 1-4
-
-
Tashiro, K.1
Koyanagi, I.2
Saitoh, A.3
-
110
-
-
0036039004
-
Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy
-
Guler S, Cakir B, Demirbas B, et al. Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy. Horm Res 2002; 58:67-70.
-
(2002)
Horm Res
, vol.58
, pp. 67-70
-
-
Guler, S.1
Cakir, B.2
Demirbas, B.3
-
111
-
-
0035991936
-
Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats
-
Kelly DJ, Wilkinson-Berka JL, Ricardo SD, et al. Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats. Nephrol Dial Transplant 2002; 17:985-991.
-
(2002)
Nephrol Dial Transplant
, vol.17
, pp. 985-991
-
-
Kelly, D.J.1
Wilkinson-Berka, J.L.2
Ricardo, S.D.3
-
113
-
-
0036190137
-
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes
-
Schrier RW, Estacio RO, Esler A, et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002; 61:1086-1097. Prospective, randomized, controlled trial evaluating the effects of five-year intensive versus moderate diastolic blood pressure control on diabetic vascular complications in 'normotensive' type 2 diabetic patients.
-
(2002)
Kidney Int
, vol.61
, pp. 1086-1097
-
-
Schrier, R.W.1
Estacio, R.O.2
Esler, A.3
-
114
-
-
0035922444
-
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
-
Parving HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345:870-878.
-
(2001)
N Engl J Med
, vol.345
, pp. 870-878
-
-
Parving, H.H.1
Lehnert, H.2
Brochner-Mortensen, J.3
-
115
-
-
0037031270
-
Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: A blood pressure-independent effect
-
Viberti G, Wheeldon NM. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect. Circulation 2002; 106:672-678. This evaluates the effects of valsartan, an angiotensin II type 1 receptor-blocker, on urinary albumin excretion rate of 332 microalbuminuric type 2 diabetic patients included in the MicroAlbuminuria Reduction with VALsartan (MARVAL) study.
-
(2002)
Circulation
, vol.106
, pp. 672-678
-
-
Viberti, G.1
Wheeldon, N.M.2
-
116
-
-
0036067729
-
Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats
-
Yamashita T, Shikata K, Matsuda M, et al. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats. Diabetes Res Clin Pract 2002; 57:149-161.
-
(2002)
Diabetes Res Clin Pract
, vol.57
, pp. 149-161
-
-
Yamashita, T.1
Shikata, K.2
Matsuda, M.3
-
117
-
-
0036969949
-
Effect of long-term administration of prostaglandin I(2) in incipient diabetic nephropathy
-
Owada A, Suda S, Hata T. Effect of long-term administration of prostaglandin I(2) in incipient diabetic nephropathy. Nephron 2002; 92:788-796.
-
(2002)
Nephron
, vol.92
, pp. 788-796
-
-
Owada, A.1
Suda, S.2
Hata, T.3
-
118
-
-
0036288407
-
Inhibitory effect of ibudilast on urinary albumin excretion in type 2 diabetes mellitus with microalbuminuria
-
Hoshino T, Ikeda T. Inhibitory effect of ibudilast on urinary albumin excretion in type 2 diabetes mellitus with microalbuminuria. Nephron 2002; 90:154-157.
-
(2002)
Nephron
, vol.90
, pp. 154-157
-
-
Hoshino, T.1
Ikeda, T.2
-
119
-
-
0036014944
-
Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: The Di.N.A.S. randomized trial
-
Gambaro G, Kinalska I, Oksa A, et al. Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial. J Am Soc Nephrol 2002; 13:1615-1625. The authors describe the results of a randomized, double-blind, placebo-controlled, multicenter, dose-range finding trial evaluating the extent and duration of the reduction in albuminuria by oral sulodexide, a glycosaminoglycan, in microalbuminuric and proteinuric type 1 and type 2 diabetic patients.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 1615-1625
-
-
Gambaro, G.1
Kinalska, I.2
Oksa, A.3
-
120
-
-
0036837092
-
Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy
-
Takahashi T, Yano M, Minami J, et al. Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy. Diabetes Res Clin Pract 2002; 58:123-129.
-
(2002)
Diabetes Res Clin Pract
, vol.58
, pp. 123-129
-
-
Takahashi, T.1
Yano, M.2
Minami, J.3
-
121
-
-
0036167784
-
A blood pressure cut-off level identified for renal failure, but not for macrovascular complications in type 2 diabetes: A 10-year observation study
-
Torffvit O, Agardh CD. A blood pressure cut-off level identified for renal failure, but not for macrovascular complications in type 2 diabetes: a 10-year observation study. Horm Metab Res 2002; 34:32-35. This longitudinal study aimed to identify the existance of a cut-off blood pressure level for major complications (myocardial infarction, stroke, renal failure or death) in patients with type 2 diabetes.
-
(2002)
Horm Metab Res
, vol.34
, pp. 32-35
-
-
Torffvit, O.1
Agardh, C.D.2
-
122
-
-
0035922447
-
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345:851-860.
-
(2001)
N Engl J Med
, vol.345
, pp. 851-860
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Clarke, W.R.3
-
123
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345:861-869.
-
(2001)
N Engl J Med
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
De Zeeuw, D.3
-
124
-
-
0035991954
-
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy
-
Jacobsen P, Andersen S, Rossing K, et al. Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy. Nephrol Dial Transplant 2002; 17:1019-1024. This evaluated the effects of the association of angiotensin II type 1 receptor-blocker with angiotensin converting enzyme inhibitor in proteinuric patients with type 1 diabetes.
-
(2002)
Nephrol Dial Transplant
, vol.17
, pp. 1019-1024
-
-
Jacobsen, P.1
Andersen, S.2
Rossing, K.3
-
125
-
-
0036369626
-
Dual blockade of the renin-angiotensin system in diabetic nephropathy: A randomized double-blind crossover study
-
Rossing K, Christensen PK, Jensen BR, et al. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study. Diabetes Care 2002; 25:95-100. These authors evaluated the effects of the association of angiotensin II type 1 receptor-blocker with ACE inhibitor in proteinuric patients with type 2 diabetes.
-
(2002)
Diabetes Care
, vol.25
, pp. 95-100
-
-
Rossing, K.1
Christensen, P.K.2
Jensen, B.R.3
-
126
-
-
0036191924
-
Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels
-
Agarwal R, Siva S, Dunn SR, et al. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels. Am J Kidney Dis 2002; 39:486-492. The study evaluated the changes on urinary TGF-β1 levels induced by an angiotensin II type 1 receptor-blocker, added to a background of chronic maximal angiotensin converting enzyme inhibitor therapy, in patients with proteinuria.
-
(2002)
Am J Kidney Dis
, vol.39
, pp. 486-492
-
-
Agarwal, R.1
Siva, S.2
Dunn, S.R.3
-
127
-
-
0036311086
-
Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy
-
Hansen HP, Tauber-Lassen E, Jensen BR, et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 2002; 62:220-228.
-
(2002)
Kidney Int
, vol.62
, pp. 220-228
-
-
Hansen, H.P.1
Tauber-Lassen, E.2
Jensen, B.R.3
-
128
-
-
0036233173
-
A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy
-
Khajehdehi P, Roozbeh J, Mostafavi H. A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy. Stand J Urol Nephrol 2002; 36:145-148.
-
(2002)
Stand J Urol Nephrol
, vol.36
, pp. 145-148
-
-
Khajehdehi, P.1
Roozbeh, J.2
Mostafavi, H.3
-
129
-
-
0036362822
-
Tranilast slows the progression of advanced diabetic nephropathy
-
Soma J, Sugawara T, Huang YD, et al. Tranilast slows the progression of advanced diabetic nephropathy. Nephron 2002; 92:693-698.
-
(2002)
Nephron
, vol.92
, pp. 693-698
-
-
Soma, J.1
Sugawara, T.2
Huang, Y.D.3
-
130
-
-
0037092913
-
Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes
-
The CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 2002; 287:2542-2551. This estimates the cost-effectiveness of intensive glycemic control, intensified hypertension control, and reduction in serum cholesterol levels for patients with type 2 diabetes based on the results of the United Kingdom Prospective Diabetes Study and other studies.
-
(2002)
JAMA
, vol.287
, pp. 2542-2551
-
-
-
131
-
-
0037061867
-
Clinical practice. Nephropathy in patients with type 2 diabetes
-
Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346:1145-1151.
-
(2002)
N Engl J Med
, vol.346
, pp. 1145-1151
-
-
Remuzzi, G.1
Schieppati, A.2
Ruggenenti, P.3
|